Enhancing Treatment Adherence in Pediatric Asthma With a Problem Solving Intervention
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the effectiveness of a tailored problem solving intervention in increasing adherence to asthma management behaviors in African American adolescents with asthma.
| Condition | Intervention |
|---|---|
|
Asthma |
Behavioral: Tailored Problem Solving Intervention Behavioral: Family Education Intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Primary Purpose: Treatment |
| Official Title: | Randomized Controlled Trial of Problem Solving Intervention to Enhance Treatment Adherence in Pediatric Asthma |
- Adherence to medical treatment, based on electronic monitors (measured at Months 3, 6, 9, and 12)
- Asthma-related morbidity, including symptoms, pulmonary functioning, and health-related quality of life (measured at Months 3, 6, 9 and 12)
| Estimated Enrollment: | 120 |
| Study Start Date: | January 2001 |
BACKGROUND:
Children and adolescents who are unable to adhere to their medical regimen for the management of chronic illness present considerable challenges to health care providers and researchers. Pediatric asthma is a chronic illness where the consequences of non-adherence are particularly detrimental and widespread, especially among economically disadvantaged minority children and their families. Studies of intervention of asthma management are needed for this population.
DESIGN NARRATIVE:
The aim of the proposed study is to test the efficacy of a problem solving intervention that is tailored to the observed adherence behaviors and identified barriers to increasing adherence in African American children and adolescents with asthma, and their families. Patients are randomized to either a Tailored Problem Solving Intervention, or a control group who will receive Family Education Intervention. Duration of the intervention is four months.
Eligibility| Ages Eligible for Study: | 6 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- African American
- Family income to be below the poverty line
- Physician-based diagnosis of asthma of at least 12 months
- Moderate to severe asthma (moderate asthma includes daily symptoms, daily use of inhaled short acting beta-agonist, exacerbations greater than 2 times per week that affect activity, and nighttime symptoms greater than once a week, FEV1 or Peak Flow PEF between 60 and 80 percent predicted and PEF variability greater than 30 percent; severe asthma includes continual symptoms, limited physical activity, frequent exacerbations together with frequent nighttime symptoms, FEV1 or PEF less than 60 percent predicted, and PEF variability greater than 30 percent)
- Likely to be on a stable and daily medication (inhaled steroid) that can be modified electronically for the time period required to participate in the study
Exclusion Criteria:
- Presence of a serious comorbid chronic condition
Contacts and Locations More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00149487 History of Changes |
| Other Study ID Numbers: | 257, R01 HL069547 |
| Study First Received: | September 6, 2005 |
| Last Updated: | November 6, 2006 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 22, 2013